Biochrom, Gilson Sign ELISA Distribution Agreement
News Jun 10, 2014
The partnership combines the strength of the EZ Read range of microplate readers from Biochrom, with Gilson’s innovative line of liquid handling systems. Used together the flexible offering enables scientists to easily automate their absorbance assays including ELISA, total protein and cell viability.
Biochrom created the EZ Read microplate reader range by matching its expertise in absorbance measurement with requests from scientists and technicians to make their experimental workflow easier and more effective. Gilson has incorporated its vast knowledge of liquid transfer techniques into a wide range of automated liquid handlers.
Tristana von Will, Global Product Marketing Manager at Biochrom, commented: “Gilson is a leader in liquid handling systems and we are delighted to be combining the heritage and expertise of both companies to co-sell our product ranges. Researchers and technicians will be very familiar with both the Biochrom and Gilson brands, but together we can further streamline experimental workflows for our customers.”
Ronan Herry, European Marketing Director at Gilson International BV, stated:” The Biochrom range of EZ Read Microplate readers fits very well with our range of liquid handling products, either for those customers who require manual or electronic multichannel pipettes from the PIPETMAN range or for those customers that would like to automate their lab work flows. The Gilson PIPETMAX comes at a size and price that is accessible to any lab and takes away the stress and strain of manual pipetting for ELISA and Bradford type assays while improving reproducibility. Adding the Biochrom range now enables Gilson to offer a complete applications solution for our customers”.
U.S. Study of Dapivirine Ring in Lactating Women Finds Little Drug Gets Into Breast MilkNews
The antiretroviral drug dapivirine that is released from an experimental vaginal ring to protect against HIV is absorbed in very low concentrations into breastmilk.READ MORE
Innate Reaction of Hematopoietic Stem Cells to Severe InfectionsNews
Researchers at the University of Zurich have shown for the first time that hematopoietic stem cells detect infectious agents themselves and begin to divide, without signals from growth factors.READ MORE
CRISPR Reveals New Targets for Promising Cancer DrugsNews
Novel screening method identifies new drug targets that could potentially enhance the effectiveness of PD-1 checkpoint inhibitors, a promising new class of cancer immunotherapy.READ MORE
Comments | 0 ADD COMMENT
EMBL Conference: European Conference of Life Science Funders and Foundations
Apr 19 - Apr 20, 2018
EMBL Course: Transgenic Animals - Micromanipulation Techniques
Apr 10 - Apr 11, 2018
EMBO Practical Course: Extracellular Vesicles: From Biology to Biomedical Applications
Apr 09 - Apr 13, 2018